Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.03.9923.1222
Address
Level 10 99 Queen Street Melbourne, Victoria (VIC) 3000
Description
Opyl Ltd. is an information technology company, which engages in the development of digital tools that improve the healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of clinical research process. Its services Opin-Clinical Trial Recuitment platform created by Opyl that leverages social media, search engine optimization technologies, and emerging artificial intelligence science, matching patients directly to clinical trials. The company was founded by Marc Angelone and Noah Abelson-Gertleron on January 17, 1994 and is headquartered in St. Kilda, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.03
Trade Value (12mth)
AU$1,117.00
1 week
11.76%
1 month
5.56%
YTD
0%
1 year
-32.14%
All time high
125919.00
EPS 3 yr Growth
-32.70%
EBITDA Margin
-805.00%
Operating Cashflow
-$2m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-7.50
Quick Ratio
0.80
Shares on Issue (Fully Dilluted)
171m
HALO Sector
Technology
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
06 March 25 |
January Investor Presentation Clarification & Retraction
×
January Investor Presentation Clarification & Retraction |
27 February 25 |
OPL - Appendix 4D & Half Year Results
×
OPL - Appendix 4D & Half Year Results |
07 February 25 |
Opyl Announces Partnership with Avion
×
Opyl Announces Partnership with Avion |
30 January 25 |
Investor Presentation - January 2025
×
Investor Presentation - January 2025 |
29 January 25 |
Quarterly Activities & Cashflow Report
×
Quarterly Activities & Cashflow Report |
29 January 25 |
OPL to Host 4C Quarterly Report Presentation
×
OPL to Host 4C Quarterly Report Presentation |
07 January 25 |
OPL Signs Landmark JV with X Firm Ltd
×
OPL Signs Landmark JV with X Firm Ltd |
20 December 24 |
Notification of cessation of securities - OPL
×
Notification of cessation of securities - OPL |
20 December 24 |
Change of Director's Interest Notice - D Rasheed
×
Change of Director's Interest Notice - D Rasheed |
20 December 24 |
Change of Director's Interest Notice - S Jain
×
Change of Director's Interest Notice - S Jain |
18 December 24 |
Application for quotation of securities - OPL
×
Application for quotation of securities - OPL |
18 December 24 |
Cleansing Notice
×
Cleansing Notice |
18 December 24 |
Application for quotation of securities - OPL
×
Application for quotation of securities - OPL |
18 December 24 |
Cleansing Notice
×
Cleansing Notice |
18 December 24 |
Application for quotation of securities - OPL
×
Application for quotation of securities - OPL |
18 December 24 |
Cleansing Notice
×
Cleansing Notice |
18 December 24 |
Notification regarding unquoted securities - OPL
×
Notification regarding unquoted securities - OPL |
18 December 24 |
Notification regarding unquoted securities - OPL
×
Notification regarding unquoted securities - OPL |
18 December 24 |
Notification regarding unquoted securities - OPL
×
Notification regarding unquoted securities - OPL |
16 December 24 |
Updated Director Interest Notice - Antanas Guoga
×
Updated Director Interest Notice - Antanas Guoga |
13 December 24 |
Change of Director's Interest Notice - Antanas Guoga
×
Change of Director's Interest Notice - Antanas Guoga |
13 December 24 |
Clarification Announcement
×
Clarification Announcement |
13 December 24 |
Notification of cessation of securities - OPL
×
Notification of cessation of securities - OPL |
11 December 24 |
OPL Signs Partnership Agreement with NeuOrphan
×
OPL Signs Partnership Agreement with NeuOrphan |
10 December 24 |
OPL Partners L39 Capital to Launch AI-Powered Biotech Fund
×
OPL Partners L39 Capital to Launch AI-Powered Biotech Fund |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.